Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesRegentis Biomaterials Ltd.

Regentis Biomaterials Ltd.

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
1.27 USD -0.06 ( 4.51%)
Last update at 2026-11-11T21:10:00Z
VOLUME
40878
Market Cap
12.71M

Momentum Score

…

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.23
Low
1.34
High
52 Week Price Range
1.23
Low
9.40
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1.33
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
4.72M
ROCE
-181.68%
Diluted EPS TTM
-23.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Income before tax -13.65M 4.80M -4.13M -1.45M
Net income -13.65M 4.80M -4.13M -1.45M
Selling general administrative 8.29M 0.71M 1.12M 0.44M
Operating income -8.62M 0.93M -1.93M -1.41M
Interest expense 0.32M 0.17M 0.17M 0.00M
Net interest income -5.26M 3.31M -2.19M -0.40M
Total revenue 0.00M 0.00M 0.00M 0.00M
Total operating expenses 8.62M -0.93M 1.93M 1.41M
Total other income expense net 0.23M 0.56M -0.01M 0.36M
Net income from continuing ops -13.65M 4.80M -4.13M -1.45M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total assets 7.62M 0.48M 0.36M 1.72M
Total liab 2.87M 41.59M 46.27M 43.78M
Total stockholder equity 4.74M -41.10M -45.91M -42.06M
Other current liab - 0.16M - -
Capital stock 0.00M 0.00M 0.00M 0.00M
Retained earnings -55.79M -42.15M -46.95M -42.81M
Cash 7.38M 0.23M 0.34M 1.24M
Total current liabilities 2.87M 6.49M 3.14M 2.61M
Net debt - 4.72M 7.27M 5.23M
Short long term debt 1.20M 4.95M 0.21M -
Total current assets 7.62M 0.48M 0.36M 1.72M
Long term debt - - 7.41M 6.47M
Accounts payable 0.27M 0.25M 0.35M 0.21M
Non current assets total 0.00M 0.00M 0.00M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Net borrowings 0.30M 0.53M 0.33M 0.00M
Total cash from financing activities 8.52M 0.53M 0.33M 0.00M
Net income -13.65M 4.80M -4.13M -1.45M
Change in cash 7.15M -0.12M -0.90M -1.50M
Begin period cash flow 0.23M 0.34M 1.24M 2.74M
End period cash flow 7.38M 0.23M 0.34M 1.24M
Total cash from operating activities -1.38M -0.64M -1.22M -1.50M
Issuance of capital stock 8.22M 0.00M 0.00M -
Capital expenditures 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.13M -1.60M 0.71M -0.12M
Other non cash items 5.26M -3.31M 2.19M 0.40M
Free cash flow -1.38M -0.64M -1.22M -1.50M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
RGNT
Regentis Biomaterials Ltd.		 -0.06
4.51%		 1.27 - - - 1.72
ISRG
Intuitive Surgical Inc		 0.21
0.05%		 450.25 43.30 31.35 12.25 7.35
ESLOF
EssilorLuxottica Société anonyme		 -11.76
5.48%		 202.74 44.84 27.62 4.07 2.49
ESLOY
Essilor International SA		 -3.10
2.95%		 101.85 41.68 27.25 3.94 2.45
BDX
Becton Dickinson and Company		 1.91
0.90%		 214.52 31.62 13.76 2.25 2.04

Profile*

Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

60, Medinat Hayehudim, Herzliya, Israel, 4676652

972 9 960 1917

https://www.regentis.co.il

Name Title Year Born
Dr. Ehud Geller Ph.D. CEO & Executive Chairman NA
Mr. Arie Gordashnikov CPA Chief Accounting Officer 1984
Dr. Dror Seliktar Ph.D. Co-Founder & Chief Scientific Officer NA
Mr. Ori Gon CFO & Chief Business Officer 1982
Dr. Galit Reske Ph.D. Chief Medical Officer 1972

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…